| HOME >> BIOLOGY >> TECHNOLOGY |
The following tables provide a comparison of our diluted earnings per
share calculated under Emerging Issues Task Force Issue No. 03-6,
"Participating Securities and the Two-Class Method under FASB Statement
No. 128", or EITF 03-6, and Financial Accounting Standards Board No. 128
"Earnings per Share", or FASB 128, in accordance with GAAP and the
non-GAAP if converted method based upon FASB 128. The non-GAAP if
converted method assumes conversion of all shares of the Company's
preferred stock into common stock as of December 31, 2005.
Upon the closing of our initial public offering on August 13, 2007, all
outstanding shares of our prior Series A through Series G convertible
preferred stock were converted into an aggregate of 34,612,503 shares of
common stock. Therefore, effective August 13, 2007, we transitioned from
computing diluted earnings per share from the two class method in
accordance with EITF 03-6 to the if converted method in accordance with
FASB 128. Net income for the year ended December 29, 2007 was allocated
between the periods during which two classes of equity securities were
outstanding and during which a single class of equity securities was
outstanding based on the respective number of days. For the year ended
December 29, 2007, two classes of equity securities were outstanding for
224 days and a single class of equity securities was outstanding for 139
days, or 61.7% and 38.3% of the total days in the twelve month reporting
period, respectively. For the three months ended December 29, 2007, a
single class of equity securities was outstanding for the entire period.
We believe that the following non-GAAP diluted earnings per share
information is relevant and useful information that can be used by
analysts, investors and other interested parties to assess our performance
on a co
'/>"/>
| SOURCE Masimo Corporation Copyright©2008 PR Newswire. All rights reserved |